Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Crocs (CROX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Crocs' reported gross margin rose from 54.7% in 2025Q4 to 66.2% in 2026Q3, and free cash flow margin recovered to 26.4%, suggesting a re-accelerating business with a durable brand-driven cost advantage.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue re-accelerated from a -6.2% decline in 2025Q3 to +4.6% growth in 2026Q3 while operating margin expanded from 15.3% to 28.0% over the same span, though the bottom-line volatility suggests non-operating items warrant further investigation.
Crocs has demonstrated robust free cash flow generation, supporting financial flexibility and shareholder returns.
The company is actively buying back shares, which can enhance earnings per share and shareholder value.
Crocs achieved record performance in 2024, indicating strong operational execution and growth.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | $3.69+11.5% vs $3.31 | $1.0B+3.9% vs $1.0B |
Q3 2026 Jul 30, 2026 | $4.55+4.6% vs $4.35 | $1.2B+2.7% vs $1.1B |
Q2 2026 Apr 30, 2026 | $2.99+7.6% vs $2.78 | $921M+2.3% vs $901M |
Q1 2026 Feb 12, 2026 | $2.29+19.3% vs $1.92 | $958M+4.4% vs $917M |
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Crocs (CROX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
CROX's DTC momentum, social media buzz and product innovation are likely to have supported Q3 sales, while tariff-related uncertainty remained a cost headwind.
In the closing of the recent trading day, Crocs (CROX) stood at $119.26, denoting a -1.43% move from the preceding trading day.
Benchmark CROX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Crocs, Inc. (CROX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $151.86 | $7.55B | 10.96 | -1.5% | 16.2% | 48.76% | — | |
| $86.71 | $11.81B | 11.07 | 9.76% | 19% | 43.56% | — | |
| $39.50 | $2.89B | 16.37 | 10.45% | 6.16% | 18.25% | 2.17% | |
| $21.33 | $1.75B | 16.61 | 6.8% | 5.55% | 25.25% | 1.91% | |
| $12.69 | $428.17M | 7.89 | 1.29% | 1.84% | 8.28% | 2.28% | |
| $38.59 | $57.11B | 18.52 | 0.19% | 6.74% | 21.24% | 4.21% |
Crocs, Inc. (CROX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Crocs, Inc. (CROX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Jul 30, 2026·SEC
Jun 10, 2026·SEC
Get notified when CROX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Crocs, Inc. (CROX) stock FAQ — growth, dividends, profitability & financials explained
Crocs, Inc. (CROX) reported $4.10B in revenue over the trailing twelve months. Revenue was $4.04B in fiscal year 2025. That is 346737% more than the $1.2M of fiscal year 2003.
Crocs, Inc. (CROX) grew revenue by 0.7% over the trailing twelve months, compared with the twelve months before.
Yes. Crocs, Inc. (CROX) earned $664.4M in net income over the trailing twelve months (a 16.2% net margin).
Crocs, Inc. (CROX) had a return on equity (ROE) of 48.8% over the trailing twelve months. That is well above the market's typical 10-15%.
Crocs, Inc. (CROX) generated $754.0M in free cash flow over the trailing twelve months.